Rabies vaccine (Novartis)

N/A

Report date: 2023/06/14 09:10:31

Base Information

Drug NameRabies vaccine (Novartis)
Drug Alias NameRabies vaccine (Novartis Vaccines and Diagnostics)RabipurRabAvert瑞必补尔
ClassificationVaccines > National Immunization Program > Non-immunization program vaccine(Class II)Vaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsRabiesVirus Diseases
Global Approved IndicationsRabies
Approved Indications in ChinaRabies
Original Approved Country/TerritoryUnited States
Original Approved Date1997/10/20
Country/TerritoryUnited StatesAustriaGermany +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesGlaxosmithkline PlcNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline PlcChiron Behring Vaccines Private Ltd
Inactive CompaniesNovartis Vaccines
Active IndicationsRabiesVirus Diseases
Inactive IndicationsN/A

Other Information

ATC CodeJ07BG01
Related LinksN/A